Announced
Completed
Financials
Tags
aesthetic dermatology
Single Bidder
dermatology
Friendly
United States
Pharmaceuticals
Majority
Acquisition
Tender Offer
Public
Completed
Domestic
Private Equity
Synopsis
Eli Lilly and Company, a manufacturer of pharmaceutical products, completed the acquisition of Dermira, a biopharmaceutical company for $1.1bn. "We are pleased to complete the acquisition of Dermira, and look forward to continuing their important work to develop new therapeutic options for patients with chronic skin conditions," Patrik Jonsson, Lilly Senior Vice President.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.